112 related articles for article (PubMed ID: 27507031)
1. Spotlight on Small-Cell Lung Cancer and Other Lung Neuroendocrine Neoplasms.
Fernandez-Cuesta L; Sexton-Oates A; Bayat L; Foll M; Lau SCM; Leal T
Am Soc Clin Oncol Educ Book; 2023 May; 43():e390794. PubMed ID: 37229617
[TBL] [Abstract][Full Text] [Related]
2. Treatment of poorly differentiated neuroendocrine carcinomas of rectum and anus with chemoradiotherapy: a single-centre evaluation.
Fløe LE; Aggerholm-Pedersen N; Tabaksblat EM
J Cancer Res Clin Oncol; 2024 Mar; 150(3):114. PubMed ID: 38448660
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and survival outcomes of colorectal mixed neuroendocrine-non-neuroendocrine neoplasms and neuroendocrine carcinoma.
Suraju MO; Freischlag K; Jacob D; Thompson D; Mckeen A; Tran C; Sherman SK; Goffredo P; Weigel RJ; Hassan I
Surgery; 2024 Mar; 175(3):735-742. PubMed ID: 37867105
[TBL] [Abstract][Full Text] [Related]
4. Poorly differentiated orbital neuroendocrine carcinoma.
Zhang YS; Jiro M; Pekmezci M; Winn B
BMJ Case Rep; 2023 Aug; 16(8):. PubMed ID: 37648277
[TBL] [Abstract][Full Text] [Related]
5. Extrapulmonary Neuroendocrine Carcinomas: Current Management and Future Perspectives.
Stumpo S; Formelli MG; Persano I; Parlagreco E; Lauricella E; Rodriquenz MG; Guerrera LP; Zurlo IV; Campana D; Brizzi MP; Cives M; La Salvia A; Lamberti G
J Clin Med; 2023 Dec; 12(24):. PubMed ID: 38137784
[TBL] [Abstract][Full Text] [Related]
6. Lurbinectedin, a DNA minor groove inhibitor for neuroendocrine neoplasms beyond small cell lung cancer.
Bhamidipati D; Subbiah V
Oncoscience; 2023; 10():22-23. PubMed ID: 37324544
[No Abstract] [Full Text] [Related]
7. Metastatic well-differentiated neuroendocrine carcinoma of the pancreas: case report and review of literature.
Martin MR; Malik UF; Mohan D; Mahmoud A
Cases J; 2009 Sep; 2():8973. PubMed ID: 19918355
[No Abstract] [Full Text] [Related]
8. Rare renal well-differentiated neuroendocrine tumors: clinical and imaging characteristics in a series of three cases.
Zeng R; Xu L; Wang J; Jin L; Ren Z; Xu K; Hong L; Chen Y; Shen X; Yu W
Quant Imaging Med Surg; 2024 Jan; 14(1):1200-1207. PubMed ID: 38223106
[No Abstract] [Full Text] [Related]
9. Molecular studies of lung neuroendocrine neoplasms uncover new concepts and entities.
Fernandez-Cuesta L; Foll M
Transl Lung Cancer Res; 2019 Dec; 8(Suppl 4):S430-S434. PubMed ID: 32038931
[No Abstract] [Full Text] [Related]
10. Author Correction: Potent suppression of neuroendocrine tumors and gastrointestinal cancers by CDH17CAR T cells without toxicity to normal tissues.
Feng Z; He X; Zhang X; Wu Y; Xing B; Knowles A; Shan Q; Miller S; Hojnacki T; Ma J; Katona BW; Gade TPF; Siegel DL; Schrader J; Metz DC; June CH; Hua X
Nat Cancer; 2024 Apr; 5(4):691. PubMed ID: 38605236
[No Abstract] [Full Text] [Related]
11. Collaborative Practice in the Management of Neuroendocrine Tumors.
Chan JA; Sommers R
J Adv Pract Oncol; 2016 Apr; 7(3):278-281. PubMed ID: 29152389
[No Abstract] [Full Text] [Related]
12. Digestive Well-Differentiated Grade 3 Neuroendocrine Tumors: Current Management and Future Directions.
Pellat A; Cottereau AS; Palmieri LJ; Soyer P; Marchese U; Brezault C; Coriat R
Cancers (Basel); 2021 May; 13(10):. PubMed ID: 34070035
[TBL] [Abstract][Full Text] [Related]
13. Well Differentiated Grade 3 Neuroendocrine Tumors of the Digestive Tract: A Narrative Review.
Pellat A; Coriat R
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32492939
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic management of poorly differentiated neuroendocrine lung tumors and neuroendocrine carcinomas of the digestive system].
Pellat A; Wislez M; Svrcek M; Hammel P; Afchain P; André T
Bull Cancer; 2016 Oct; 103(10):880-895. PubMed ID: 27507031
[TBL] [Abstract][Full Text] [Related]
15. Advances in the Diagnosis and Management of Well-Differentiated and Intermediate-Differentiated Neuroendocrine Tumors of the Lung.
Wolin EM
Chest; 2017 May; 151(5):1141-1146. PubMed ID: 27373769
[TBL] [Abstract][Full Text] [Related]
16. [Neuroendocrine carcinoma of the digestive tract: a literature review].
Jacob J; Chargari C; Helissey C; Ferrand FR; Ceccaldi B; Le Moulec S; Bauduceau O; Fayolle M; Védrine L
Rev Med Interne; 2013 Nov; 34(11):700-5. PubMed ID: 23871177
[TBL] [Abstract][Full Text] [Related]
17. Current concepts in the diagnosis and management of poorly differentiated gastrointestinal neuroendocrine carcinomas.
Koumarianou A; Chatzellis E; Boutzios G; Tsavaris N; Kaltsas G
Endokrynol Pol; 2013; 64(1):60-72. PubMed ID: 23450449
[TBL] [Abstract][Full Text] [Related]
18. Management of neuroendocrine carcinomas of the pancreas (WHO G3): A tailored approach between proliferation and morphology.
Crippa S; Partelli S; Belfiori G; Palucci M; Muffatti F; Adamenko O; Cardinali L; Doglioni C; Zamboni G; Falconi M
World J Gastroenterol; 2016 Dec; 22(45):9944-9953. PubMed ID: 28018101
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
